0001415889-24-020004.txt : 20240723
0001415889-24-020004.hdr.sgml : 20240723
20240723204245
ACCESSION NUMBER: 0001415889-24-020004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240719
FILED AS OF DATE: 20240723
DATE AS OF CHANGE: 20240723
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tahir Misbah
CENTRAL INDEX KEY: 0001787359
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39045
FILM NUMBER: 241135911
MAIL ADDRESS:
STREET 1: 325 E. MIDDLEFIELD ROAD
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IGM Biosciences, Inc.
CENTRAL INDEX KEY: 0001496323
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 770349194
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 325 E MIDDLEFIELD ROAD
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-965-7873
MAIL ADDRESS:
STREET 1: 325 E MIDDLEFIELD ROAD
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
FORMER COMPANY:
FORMER CONFORMED NAME: Palingen, Inc.
DATE OF NAME CHANGE: 20100712
4
1
form4-07242024_120741.xml
X0508
4
2024-07-19
0001496323
IGM Biosciences, Inc.
IGMS
0001787359
Tahir Misbah
C/O IGM BIOSCIENCES, INC.
325 E MIDDLEFIELD ROAD
MOUNTAIN VIEW
CA
94043
false
true
false
false
CHIEF FINANCIAL OFFICER
0
Common Stock
2024-07-19
4
A
0
33111
A
121959
D
Common Stock
2024-07-19
4
A
0
2222
A
124181
D
Stock Option (right to buy)
40.27
2024-07-19
4
D
0
55000
D
2030-02-05
Common Stock
55000
0
D
Stock Option (right to buy)
91.50
2024-07-19
4
D
0
40000
D
2031-02-19
Common Stock
40000
0
D
These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-half of the RSUs shall vest on July 19, 2025 and one-eighth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.
Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 55,000 shares and 40,000 shares of the Issuer's Common Stock and in exchange issued aggregate RSU grants of 33,111 shares and 2,222 shares.
These securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-half of the RSUs shall vest on January 19, 2026 and one-twelfth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.
/s/ Misbah Tahir
2024-07-23